APERTURA GENE THERAPY

Serial Number 90803113
Registration 6987401
700

Registration Progress

Application Filed
Jun 30, 2021
Under Examination
Jun 21, 2022
Approved for Publication
Apr 26, 2022
Published for Opposition
Apr 26, 2022
Registered
Feb 21, 2023

Trademark Image

APERTURA GENE THERAPY

Basic Information

Serial Number
90803113
Registration Number
6987401
Filing Date
June 30, 2021
Registration Date
February 21, 2023
Published for Opposition
April 26, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 21, 2023
Registration
Registered
Classes
042

Rights Holder

APERTURA GENE THERAPY, LLC

16
Address
345 PARK AVE., SOUTH, 5TH FLOOR
NEW YORK, NY 10010

Ownership History

Deerfield Management Company, L.P.

Original Applicant
13
New York, NY

Deerfield Management Company, L.P.

Owner at Publication
13
New York, NY

Deerfield Management Company, L.P.

Original Registrant
13
New York, NY

APERTURA GENE THERAPY, LLC

New Owner After Registration #1
16
NEW YORK, NY

Legal Representation

Attorney
J. Dickson Phillips, III

USPTO Deadlines

Next Deadline
1156 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230221)
Due Date
February 21, 2029
Grace Period Ends
August 21, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Jul 5, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Feb 21, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Feb 21, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 14, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jan 13, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Nov 27, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Nov 4, 2022 IUAF S USE AMENDMENT FILED Loading...
Nov 27, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 4, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 21, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 26, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 26, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 6, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 23, 2022 FIXD O ELECTRONIC RECORD REVIEW COMPLETE Loading...
Mar 18, 2022 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Mar 15, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 14, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 14, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 14, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 11, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 11, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 11, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 11, 2022 RFTP Z REMOVED FROM TEAS PLUS Loading...
Dec 22, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 12, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 3, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Research and development in the field of gene therapy for the treatment of human and animal disease
First Use Anywhere: Apr 26, 2022
First Use in Commerce: Apr 26, 2022

Additional Information

Translation
The English translation of "APERTURA" in the mark is "OPENING".

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"GENE THERAPY"